BEAMSTART Logo

HomePeopleProfile

Andrew Kruegel

Founder, Gilgamesh Pharmaceuticals 


Join Date

October 2024

Gender

Not Specified

Age

Not Specified


About Andrew Kruegel

I am a medicinal chemist, pharmacologist, and entrepreneur with extensive experience in the design and preclinical development of psychoactive drugs for the future treatment of psychiatric illnesses. In the context of my entrepreneurial endeavors I have also built significant expertise in business, fundraising, operations, and intellectual property strategy.

Companies & Work

Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Share This Profile

Featured Members from United States

Srijan Kumar

CEO & Co-founder, Lighthouz AI

Arya Marwaha

Founder, Contrario

Abdul Basharat

Founder, Cartage

Ignacio De saralegui

Sales & Marketing Director at Tempos Vega Sicilia Founder, Ultra High Net Worth Conclave.

James Smith

Owner of Neurolyne

Usama Syed

Founder, FutureClinic

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.